With a full scope of services from First in Human through Proof of Concept, PAREXEL's early phase operational teams are right where you need us. With a global network of clinical units testing compounds and devices in healthy volunteers and patients, we can help you make valuable decisions quickly and safely. PAREXEL Early Phase can help you make better decisions - faster. Our consistent delivery of timely results and high quality data adds value now - and greater value in the long term, providing expertise and advice to help you collect the right data and mitigate risk of Phase III failure.
PAREXEL Early Phase understand the importance of rapid recruitment solutions in drug development. We have one of the largest global databases of healthy volunteers and over 70 diverse patient populations available in-house directly through our global network of clinical units.
We are a leading global bio/pharmaceutical services organization that helps clients expedite time-to-market through our development and launch services. These include a broad range of clinical development capabilities, integrated advanced technologies, regulatory affairs consulting, and commercialization services.